Prescription drug · UNAPPROVED DRUG OTHER
Betaloan SUIK NDC 76420-240
betamethasone sodium phosphate and betamethasone acetate · Betamethasone sodium phosphate 3 mg/mL; Betamethasone acetate 3 mg/mL · Injection, Suspension · Intra-articular, Intralesional, Intramuscular · Asclemed USA, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 76420-240-01 | 76420024001 | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-240-01) / 5 mL in 1 VIAL, MULTI-DOSEMarketed from Apr 28, 2010 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Betaloan SUIK
- Generic name (nonproprietary)
- betamethasone sodium phosphate and betamethasone acetate
- Active ingredients
- Betamethasone sodium phosphate — 3 mg/mLBetamethasone acetate — 3 mg/mL
- Dosage form
- Injection, Suspension
- Route
- Intra-articular, Intralesional, Intramuscular
- Labeler
- Asclemed USA, Inc.
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 76420-240_ead42ac0-5d53-308b-e053-2a95a90a6407SPL ID ead42ac0-5d53-308b-e053-2a95a90a6407SPL set ID aec36d73-d753-4690-9e0e-a8ac7610855eUNII 7BK02SCL3W, TI05AO53L7
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N476420024001followed by a unit qualifier and the quantityPackage 76420-0240-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE When oral therapy is not feasible, the intramuscular use of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension is indicated as follows: Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic Diseases Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine Disorders Congenital adrenal hyperplasia, hyp…
Excerpt only. Read the full label for complete information.